Bi-Specific Fusion Proteins
US-2024101713-A1 · Mar 28, 2024 · US
US9587006B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9587006-B2 |
| Application number | US-201113577284-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 4, 2011 |
| Priority date | Feb 11, 2010 |
| Publication date | Mar 7, 2017 |
| Grant date | Mar 7, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Herein is reported a method for producing of a polypeptide conjugated to one poly (ethylene glycol) comprising a) providing a nucleic acid encoding an expression construct comprising in 5′ to 3′ direction a nucleic acid encoding a polypeptide, and a nucleic acid encoding a trypsin site of SEQ ID NO: 01, b) expressing the nucleic acid of a) in a cell and recovering the expression construct from the cell and/or the cultivation medium, c) providing a target peptide with an amino acid sequence of SEQ ID NO: 02 covalently conjugated to a poly (ethylene glycol) at the C-terminal lysine residue, d) incubating the expression construct and the target peptide with the trypsin mutant D189K, K60E, N143H, E151H, and e) recovering and thereby producing the polypeptide conjugated to one poly (ethylene glycol) from the incubation mixture.
Opening claim text (preview).
The invention claimed is: 1. A polypeptide consisting of the amino acid sequence of SEQ ID NO: 28 that is conjugated to poly (ethylene glycol) at the C-terminal lysine residue of the polypeptide. 2. A pharmaceutical composition comprising the polypeptide according to claim 1 . 3. A polypeptide consisting of the amino acid sequence of SEQ ID NO: 29 that is conjugated to poly (ethylene glycol) at the C-terminal lysine residue of the polypeptide.
Tetrapeptides · CPC title
produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00) · CPC title
the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol · CPC title
Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 · CPC title
by covalent attachment of amino acids or peptide residues · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.